Skip to main content
Log in

Extracorporeal liver support in patients with liver failure

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Alshamsi F, Alshammari K, Belley-Cote E, Dionne J, Albrahim T, Albudoor B, Ismail M, Al-Judaibi B, Baw B, Subramanian RM, Steadman R, Galusca D, Huang DT, Nanchal R, Al Quraini M, Yuan Y, Alhazzani W, Group G (2019) Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. Intensive Care Med. https://doi.org/10.1007/s00134-019-05783-y

    Article  PubMed  Google Scholar 

  2. Banayosy AE, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R (2004) First use of the molecular adsorbent recirculating system technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 50(4):332–337. https://doi.org/10.1097/01.mat.0000131251.88146.cd

    Article  PubMed  Google Scholar 

  3. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R (1988) Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94(5):1186–1192. https://doi.org/10.1016/0016-5085(88)90011-x

    Article  PubMed  CAS  Google Scholar 

  4. Zhou YD, Han QF, Tang QB, Cheng YL, Shi JX (2017) Clinical effect of combined artificial extracorporeal liver support therapy for toxic hepatic failure. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 35:51–53. https://doi.org/10.3760/cma.j.issn.1001-9391.2017.01.013

    Article  PubMed  CAS  Google Scholar 

  5. Qin G, Shao J-G, Wang B, Shen Y, Zheng J, Liu X-J, Zhang Y-Y, Liu Y-M, Qin Y, Wang L-J (2014) Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure. Medicine 93(28):e338. https://doi.org/10.1097/md.0000000000000338

    Article  PubMed  PubMed Central  Google Scholar 

  6. Thompson J, Jones N, Al-Khafaji A, Malik S, Reich D, Munoz S, MacNicholas R, Hassanein T, Teperman L, Stein L, Duarte-Rojo A, Malik R, Adhami T, Asrani S, Shah N, Gaglio P, Duddempudi A, Borg B, Jalan R, Brown R, Patton H, Satoskar R, Rossi S, Parikh A, ElSharkawy A, Mantry P, Sher L, Wolf D, Hart M, Landis C, Wigg A, Habib S, McCaughan G, Colquhoun S, Henry A, Bedard P, Landeen L, Millis M, Ashley R, Frank W, Henry A, Stange J, Subramanian R (2018) Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial. Liver Transpl 24(3):380–393. https://doi.org/10.1002/lt.24986

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bo Qin.

Ethics declarations

Conflicts of interest

The authors declare that they have no competing interest.

Ethical approval

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 1365 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, X., Qin, B. Extracorporeal liver support in patients with liver failure. Intensive Care Med 46, 829–830 (2020). https://doi.org/10.1007/s00134-020-05928-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-020-05928-4

Navigation